"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Over The Counter (OTC) Drugs market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Over The Counter (OTC) Drugs market." Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. The global Over The Counter (OTC) Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Over The Counter (OTC) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Over The Counter (OTC) Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: Bayer AG Boehringer Ingelheim GlaxoSmithKline PLC Johnson & Johnson Novartis International AG Pfizer,Inc. PGT healthcare Sanofi S.A Takeda Segment by Regions North America Europe China Japan Segment by Type Analgesics Dermatology Products Gastrointestinal Products Vitamins, Mineral, and Supplements (VMS) Weight Loss/Dietary Products Ophthalmic Products Sleeping Aids Others Segment by Application Hospital Pharmacies Retail Pharmacies Online Pharmacy Others
Table of Contents Executive Summary 1 Over The Counter (OTC) Drugs Market Overview 1.1 Product Overview and Scope of Over The Counter (OTC) Drugs 1.2 Over The Counter (OTC) Drugs Segment by Type 1.2.1 Global Over The Counter (OTC) Drugs Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Analgesics 1.2.3 Dermatology Products 1.2.4 Gastrointestinal Products 1.2.5 Vitamins, Mineral, and Supplements (VMS) 1.2.6 Weight Loss/Dietary Products 1.2.7 Ophthalmic Products 1.2.8 Sleeping Aids 1.2.9 Others 1.3 Over The Counter (OTC) Drugs Segment by Application 1.3.1 Over The Counter (OTC) Drugs Consumption Comparison by Application (2014-2025) 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacy 1.3.5 Others 1.4 Global Over The Counter (OTC) Drugs Market by Region 1.4.1 Global Over The Counter (OTC) Drugs Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Over The Counter (OTC) Drugs Market Size 1.5.1 Global Over The Counter (OTC) Drugs Revenue (2014-2025) 1.5.2 Global Over The Counter (OTC) Drugs Production (2014-2025) 2 Global Over The Counter (OTC) Drugs Market Competition by Manufacturers 2.1 Global Over The Counter (OTC) Drugs Production Market Share by Manufacturers (2014-2019) 2.2 Global Over The Counter (OTC) Drugs Revenue Share by Manufacturers (2014-2019) 2.3 Global Over The Counter (OTC) Drugs Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Over The Counter (OTC) Drugs Production Sites, Area Served, Product Types 2.5 Over The Counter (OTC) Drugs Market Competitive Situation and Trends 2.5.1 Over The Counter (OTC) Drugs Market Concentration Rate 2.5.2 Over The Counter (OTC) ... | read more...